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Abstract
Background: The indications for nephron-sparing surgery are expanding constantly. One major
contributing fact for this development is the improvement of haemostatic techniques following
excision of the tumor. Nevertheless, postoperative bleeding complications still occur. To prevent
this, we prospectively studied the effect of application of small-intestine submucosa (SIS) over the
renal defect.
Methods: We performed 55 nephron-sparing surgeries applying SIS between 08/03 and 10/06 in
53 pts. (mean age: 59 yrs., range 29 – 79 yrs.). After resection of the renal tumor and application
of a haemostyptic agent, we used SIS to secure and apply compression on the defect.
Results:  The final pathology revealed clear-cell and papillary carcinoma, papillary adenoma,
oncocytoma, and angiomyolipoma in 39 (70.9%), 6 (10.9), 1 (1.8%), 2 (3.6%) and 7 (12.7%) patients,
respectively. The 45 malignant lesions (81.8%) were classified as pT1a and pT1b in 35 (77.8%) and
10 (22.2%) patients, respectively. The median tumor size was 4.5 cm (range: 1.3 – 13 cm). The
median operating time was 186 min (range: 90 – 260 min). 18 (32.7%) procedures were performed
without ischemia. 23 (41.8%) and 14 (25.5%) cases were operated in in-situ cold and warm
ischemia, respectively. The median intraoperative blood loss was 730 cc (range: 100 – 2500 cc). No
open operative revision was indicated due to postoperative bleeding complications. Furthermore,
there was no necessity to substitute persistent blood loss from the drains postoperatively. No
urinoma occurred.
Conclusion: SIS is a highly effective and easy-to-use instrument for preventing postoperative
bleeding and urinary fistula complications in nephron-sparing surgery.
Background
Nephron-sparing surgery provides effective therapy for
patients that require preservation of renal function [1].
Furthermore, due to the low recurrence rates and excellent
survival rates of nephron-sparing surgery in patients with
renal tumors 4 cm or smaller, nephron-sparing surgery
has become an accepted alternative treatment for patients
with normal renal function [1].
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The reported major complications after in-situ nephron-
sparing surgery for solid renal lesions are urinary fistulas
(2.1% to 17.4%), infections/abscesses (0.6% to 6.0%)
and bleedings (0% – 7.9%), resulting in an overall re-
operation rate of 0% to 3.1% [1]. Several technical consid-
erations to prevent these complications have been propa-
gated: watertight closure of the collecting system, rigorous
ligation of vessels and reconstruction of the renal remnant
over a haemostatic agent [1]. These principles resulted in
a dramatic decrease of the complication rates following
nephron-sparing surgery in the last decades [2,3].
Porcine small-intestine submucosa (SIS, Surgisis® Soft Tis-
sue Graft, COOK Biotech, West-Lafayette, Ind, USA) is a
natural acellular biomaterial based on collagen from the
porcine submucosa. SIS does not induce major adverse
reactions when surgically implanted and is gradually
remodeled, leaving behind autologous tissue. The mem-
brane is used for different purposes in urology, obstetrics
and gynaecology, general surgery and wound care [4,5].
We describe our experience with SIS in optimizing the
outcome in nephron-sparing surgery.
Methods
Between 08/03 and 10/06, all patients received a SIS to
secure and apply compression to the defect following an
open nephron-sparing surgery by two surgeons (JS, RP).
The patients were placed in a supine position. The retro-
peritoneal space was exposed by placing a pillow under
the flank. The skin was incised transversally from the tip
of the 11th rib medially towards the epigastrium. The ret-
roperitoneum was exposed and the Gerota's fascia was
opened. The peritoneal sac was pushed medially. This
maneuver exposed the aorta or the inferior caval vein as
leading structure for further preparation. The kidney was
freed from the perirenal fat. The fat overlying the tumor
was sent for pathological examination. The renal artery
and vein were identified and isolated with vessel loops.
The renal capsule around the tumor was incised with a
safety margin around the tumor. The tumor was bluntly
dissected and excised with a margin of normal tissue using
scissors or a Leriche dissector.
In patients with warm ischemia or cold perfusion, the
patient received intravenous mannitol and furosemid
prior to clamping to ensure adequate diuresis and to scav-
enge free radicals to decrease reperfusion injury. The renal
artery and vessels were temporarily occluded with bulldog
clamps or vessel clamps. In cases with central or large
tumors where the anticipated time of warm ischemia
could exceed 30 min, we performed an in-situ cold per-
fusion using Bretschneider solution (Composition:
Sodium, Potassium, Magnesium, Chloride, Tryptophan,
Potassium-α-ketoglutarate, Histidine-hydrochloride and
Mannitol) as previously reported [6]. Briefly, after clamp-
ing of the renal artery, a longitudinal arteriotomy incision
was made with a scalpel and extended with Pott's scissors.
A 10 to 12 Ch. perfusion catheter was used to apply the
solution. The renal vein was clamped and a longitudinal
incision was made with a scalpel, or alternatively the left
gonadal vein was divided. Immediately after these steps
began the perfusion of the kidney with a hydrostatic pres-
sure of 55 to 75 cm water. Continuous perfusion was
maintained throughout the entire ischemia time. Follow-
ing resection of the tumor and application of the SIS (see
below), the vessels were closed with interrupted 6-zero
polypropylene vascular sutures.
Visible blood vessels within the renal defect were ligated.
The collecting system was closed with chromic sutures.
For greater defects in the collecting system, a pyelostomy
catheter was inserted. A haemostyptic agent [(FloSeal®
(Baxter, Deerfield, IL, USA), TachoSil® (Nycomed, Unter-
schleissheim, Germany), or TachoComb®  (Nycomed,
Unterschleissheim, Germany)] was transferred into the
defect and the renal capsule was slightly approximated
with interrupted sutures. The multilayered hydrated SIS
was cut into shape. In the first 16 cases the SIS was fixed
over the parenchymal defect using figure-of-eight chromic
sutures. Care was taken to stitch the renal surface superfi-
cially to avoid parenchymal scarring caused by deep
sutures. The direction of compression to the renal defect is
different from the one applied by horizontal mattress
sutures (Fig. 1). In the following 7 cases we used a running
suture. In the remaining patients the hydrated SIS was
tightened over the renal defect with a running suture
mimicking the fixation of a drumhead (Fig. 2). A percuta-
neous drainage was placed to monitor bleeding and uri-
nary leakage.
Results
Between 08/2003 and 10/2006 we performed 55 neph-
ron-sparing procedures using SIS in 53 patients (median
age: 59 yrs, range 29 – 79 yrs) (Fig. 3). The preoperative
diagnostics revealed a solid lesion, suspicious for a malig-
nant tumour or an angiomyolipoma in 48 (87.3%) and 7
lesions (12.7%), respectively. The indication for nephron-
sparing surgery was elective in 38/53 (71.7%) patients. 6/
53 patients (5.7%) had a single kidney, 3/53 patients
(2.8%) had multiple renal tumors, 5/53 patients (4.7%)
revealed an impaired renal function and 1/53 patient
(0.9%) pts. had a tumor in the transplanted kidney.
According to the tumor location within the kidney and
the tumor size 23/55 (41.8%), lesions were operated with
in-situ cold perfusion. 18/55 (32.7%) and 14/55 (25.5%)
of the tumors were resected without hilar control and with
warm ischemia, respectively. Generally, it took 5 – 10 minBMC Urology 2008, 8:8 http://www.biomedcentral.com/1471-2490/8/8
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to fix the SIS. The mean time of cold perfusion and warm
ischemia was 69 min (range 37 – 145 min) and 18 min (5
– 29 min). The median operating time was 186 min
(range 90 – 260 min) and the median blood loss was 730
cc (range 100 – 2500 cc). Perioperative (intraoperative or
immediate postoperative) blood transfusion was required
in 16 (29.1%) procedures.
The median tumor size was 4.5 cm (range 1.3 to 13 cm).
The final pathology revealed a clear cell carcinoma in 39
cases (70.9%), a papillary carcinoma in 6 patients
(10.9%), a papillary adenoma in 1 (1.8%), an oncocy-
toma in 2 (3.6%) and an angiomyolipoma in 7 cases
(12.7%), respectively. All the tumors were resected in
sano with negative margin status.
Concerning the postoperative complications, one patient
(0.9%) died from a cerebral ischemia after surgery. One
patient (0.9%) underwent relaparotomy due to postoper-
ative bleeding from a failed suture of the venotomy fol-
lowing in-situ cold perfusion immediately after the
primary surgical procedure. Minor continuous bleeding
from a segmental renal artery following resection of an
angiomyolipoma required interventional coiling in one
further patient (0.9%) on postoperative day 3. Marked
haematuria was the main symptom in this patient. In one
patient (0.9%) a postoperative urinary leakage from the
collecting system was noticeable. After the insertion of a
double-J-catheter on day 4 following the nephron-sparing
surgery, the fistula closed without any further intervention
and without urinoma formation. In one patient (0.9%)
we performed a postoperative CT scan to evaluate pro-
longed haematuria on postoperative day 6. Only blood
clots were present in the resection area. However, no fur-
ther active bleeding was detected in the CT scan. In this
patient, the SIS membrane secured the defect and stopped
the bleeding by compressing the defect (Fig. 4). In no
patient was an open operative revision due to postopera-
tive haemorrhage from the surgical site indicated. Further-
more, no transfusions were necessary to substitute
persistent blood loss from drains postoperatively.
Discussion
On a standard basis, nephron-sparing surgery has been
used in patients with a renal cell carcinoma having a soli-
tary kidney, bilateral synchronous tumors or a systemic
disease that could potentially jeopardize renal function
[7]. However, due to the recently published promising
cancer-free survival rates of patients undergoing nephron-
sparing surgery for tumors less than 4 cm, this approach
gains widespread acceptance in patients with a normally
functioning contralateral kidney [8-10]. Furthermore, Lei-
bovich et al. [11] demonstrated that even patients with
renal cell carcinoma from 4 to 7 cm treated with nephron-
sparing surgery had an excellent cancer-specific and
metastases-free survival when the tumors had an exo-
phytic growth pattern and presented with minimal risk of
invasion of the collecting system. These promising onco-
logical results, combined with advances in renal imaging
Comparison of the direction of the compression of the defect with SIS (A) and horizontal mattress sutures (B) Figure 1
Comparison of the direction of the compression of the defect with SIS (A) and horizontal mattress sutures 
(B).
Scheme of the fixation of the SIS with a running suture, mim- icking the fixation of a drumhead Figure 2
Scheme of the fixation of the SIS with a running 
suture, mimicking the fixation of a drumhead.
SIS
running sutureBMC Urology 2008, 8:8 http://www.biomedcentral.com/1471-2490/8/8
Page 4 of 6
(page number not for citation purposes)
and improved surgical techniques, led to an increase of
nephron-sparing procedures.
The critical steps during nephron-sparing surgery are the
resection of the tumor with an adequate margin of benign
tissue around the tumor, as well as a sufficient haemosta-
sis and closure of the collecting system. The surgical tech-
nique applied depends on the size and location of the
renal tumor.
In little peripheral renal masses, haemostasis may be
achieved after tumor resection using coagulation and a
haemostyptic agent without any sutures. Finley et al. [12]
reported on a series of 15 patients who underwent a
sutureless haemostasis after excision of small renal masses
(range 1.1 to 3.5 cm) using a fibrin glue – oxidized cellu-
lose sandwich. Otherwise, the mainstay of haemostasis
has to be accomplished by compressing the tissue around
the renal defect. Usually, for this purpose the renal capsule
is sutured with horizontal mattress sutures over the length
of the defect [13]. There is a theoretical possibility of loss
of functional kidney tissue due to scarring caused by the
suture line passing through the renal capsule and paren-
chyma, even though to date no experimental data exist
supporting this hypothesis. The maximum tensile force
that may be applied onto the sutures is limited by the ten-
sile strength of the renal capsule and parenchyma. The
tearing of the suture through the capsule is of major con-
cern. Therefore, alternative methods to buttress the clo-
sure of the renal parenchyma using exogenous material
like Gore-Tex [13] or Teflon [14] have been investigated.
The exogenous materials prevent the tearing of the sutures
through the renal parenchyma, leading to a tighter, more
haemostatic and watertight closure of the defect [13].
In the case of larger defects, the renal parenchyma has to
be folded to close the defect with sutures. Therefore, the
closure is hard to achieve and associated with a greater risk
of complications [2]. In these cases, the use of exogenous
materials like perirenal fat or oxidized cellulose was prop-
agated to cover the defect [15,16]. Wainstein et al. [17]
Surgisis® Soft Tissue Graft (SIS technology) covering the renal defect, fixed with a running suture with a pyelostomy catheter in  place Figure 3
Surgisis® Soft Tissue Graft (SIS technology) covering the renal defect, fixed with a running suture with a 
pyelostomy catheter in place.
SIS
pyelostomy catheter
CT scan of a patient with bleeding from the tumor bed Figure 4
CT scan of a patient with bleeding from the tumor 
bed. The SIS secured the defect and stopped the bleeding by 
compressing the defect.BMC Urology 2008, 8:8 http://www.biomedcentral.com/1471-2490/8/8
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successfully used a polyglycolic acid mesh in three
patients to obtain a secure closure of a renal defect [17]. In
a recent study, O'Connor et al. [18] described the use of
SIS to cover the defect in 24 partial nephrectomies. In
their study, haemostasis was achieved by excising the
defect with a harmonic scalpel, using coagulation of the
parenchyma with an argon beam, ligation of visible ves-
sels and closing the collecting system with interrupted,
chromic sutures. The SIS was placed over the defect with
several figure-of-eight chromic sutures.
Compared to the study by O'Connor et al. [18], we opti-
mized the haemostyptic procedure. To minimize the loss
of functional kidney tissue, we used neither a harmonic
scalpel to excise the tumor nor the argon beamer to coag-
ulate the parenchyma. The adverse effect of coagulation
on the remaining renal parenchyma was demonstrated in
the study by Murphy et al. [19]. Microscopic changes of
the renal parenchyma caused by the applied heat were
noted as deep as 1 cm below the surface area. To achieve
haemostasis, we ligated visible vessels and applied a hae-
mostyptic agent. Furthermore, we only slightly approxi-
mated the edges of the kidney without applying tension
on the renal capsule. Finally, we fixed the hydrated SIS
more tightly over the renal defect with a running suture
mimicking the fixation of a drumhead. This led to a uni-
form tension on the renal defect (Fig. 1).
The intraoperative blood loss (median 730 cc) and trans-
fusion rate (29.1%) in the present study is comparable to
the literature [20-23]. Furthermore, the reported inci-
dence of postoperative bleeding complications and uri-
nary fistulas following nephron-sparing surgery is 0 –
7.9% and 1 – 10.1%, respectively (see Table 1) [3,9,20,22-
26]. However, when comparing the data in the literature,
it is mandatory to consider the diameter of the renal
lesions. Due to the broadening of the indication for elec-
tive nephron-sparing surgery in recent years, only few
studies exist reporting complication rates in series with
larger tumors such as we present in our study. Both the
postoperative bleeding and urinary leakage rates were
1.8%. These results are superior to recent studies with
comparable tumor size, reporting bleeding rates of 2.9%
and urinary leakage rates of 5.8% and 10.1% [20,24].
Conclusion
In expanding the indications for nephron-sparing surgery,
there is a need to establish reliable techniques to excise the
tumor and prevent postoperative complications even in
larger tumors. In this context, SIS has proven to be a
highly effective and easy-to-use instrument for preventing
postoperative bleeding and urinary fistula complications.
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